Oshi Health has raised $60 million in funding from Oak HC/FT and a group of other prominent existing investors like Flare Capital Partners, Takeda Digital Ventures, Bessemer Venture Partners, Frist Cressey Ventures, and CVS Health Ventures in a Series C financing round.
Oshi Health, which is in the digestive healthcare space, is now planning to use this funding to go into nationwide expansion. This funding will fuel the growth of the company exponentially and will help it to position itself as one of the top virtual gastrointestinal (GI) care providers in the country. The company is planning to forge new partnerships with more provider groups and to partner with companies so that they can offer its services to their employees.
As we know, digestive system-related issues are now common ones in today’s era and are affecting millions of people across the globe. And with the rise of healthcare costs across America, it is now more important than ever to have some affordable treatments, something like Oshi Health provides. Its platforms provide 360 degress solution for digestive system-related issues, like symptom management, integrated care, and Multidisciplinary Care with a dedicated team, all these together by keeping the costs lower than market competitors.
Sam Holliday is the Co-founder and CEO at Oshi Health, and he is also a member of the board of the Health Care Transformation Task Force. Apart from this, he is also a founding member of the V1C Coalition by DiMe.
Swastik Saraf is the Founder and Managing Editor of TheMedSector. With a background in data journalism and healthcare research, he specializes in aggregating public health metrics, analyzing institutional data, and mapping out regional healthcare infrastructure. Swastik leads the data compilation team at TheMedSector, ensuring all directory tracking is built on verified primary sources before undergoing formal clinical review.
